ArticleJournal of cancer research and clinical oncology2024

TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis.

Shaolin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.